Sandoz Private Limited — Furosemide Exporter Profile
Indian Pharmaceutical Exporter · #7 for Furosemide · $2.3M export value · DGFT Verified
Sandoz Private Limited is the #7 Indian exporter of Furosemide with $2.3M in export value and 88 verified shipments. Sandoz Private Limited holds a 3.3% market share in Furosemide exports across 2 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.
Sandoz Private Limited — Furosemide Export Profile: Buyers & Destinations
Where Does Sandoz Private Limited Export Furosemide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $2.0M | 64 | 88.2% |
| SLOVENIA | $264.3K | 24 | 11.8% |
Sandoz Private Limited exports Furosemide to 2 countries. The largest destination is GERMANY accounting for 88.2% of Sandoz Private Limited's Furosemide shipments. These destinations reflect Sandoz Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Furosemide from Sandoz Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SALUTAS PHARMA GMBH | GERMANY | $2.0M | 64 |
| LEK D.D | SLOVENIA | $97.4K | 5 |
| NOVARTIS LLC | SLOVENIA | $50.2K | 15 |
| LEK D D PM PRODUCTION MATERIALS | SLOVENIA | $50.0K | 1 |
| LEK D.D. | SLOVENIA | $41.4K | 1 |
| LEK D.D.- PM # PRODUCTION MATERIALS | SLOVENIA | $25.3K | 2 |
Sandoz Private Limited supplies Furosemide to 6 buyers globally. The largest buyer is SALUTAS PHARMA GMBH (GERMANY), followed by LEK D.D (SLOVENIA) and NOVARTIS LLC (SLOVENIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Furosemide Export Value and How Much Does Sandoz Private Limited Contribute?
India exported $43.6M worth of Furosemide through 4,657 shipments from 333 suppliers to 150 countries, serving 778 buyers globally. Sandoz Private Limited contributes $2.3M to this total, accounting for 3.3% of India's Furosemide exports. Sandoz Private Limited ships Furosemide to 2 countries through 6 buyers.
What Is the Average Shipment Value for Sandoz Private Limited's Furosemide Exports?
Sandoz Private Limited's average Furosemide shipment value is $26.4K per consignment, based on 88 shipments totaling $2.3M. The largest destination is GERMANY (88.2% of Sandoz Private Limited's Furosemide exports).
How Does Sandoz Private Limited Compare to Other Indian Furosemide Exporters?
Sandoz Private Limited ranks #7 among 333 Indian Furosemide exporters with a 3.3% market share. The top 3 exporters are GRAVITI PHARMACEUTICALS PRIVATE LIMITED ($14.3M), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($7.1M), IPCA LABORATORIES LIMITED ($3.4M). Sandoz Private Limited processed 88 shipments to 2 destination countries.
What Furosemide Formulations Does Sandoz Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERI | $499.5K | 12 |
| FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERIAL NO - 42024057 | $254.6K | 7 |
| MATERIAL NO - 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $227.0K | 6 |
| FUROSEMIDE TAB 125MG IN91 SH EU 01 MATER | $158.8K | 6 |
| FUROSEMIDE TAB 500MG IN91 SH EU 01 MATER | $150.0K | 3 |
| Material No. - 42024057, FUROSEMIDE TAB | $139.0K | 4 |
| Material No. - 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $85.4K | 2 |
| FUROSEMIDE TAB 250MG IN91 SH EU 01 MATER | $76.2K | 3 |
| MATERIAL NO. 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $64.9K | 6 |
| Material No 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 BATCH NO MS9277 MS9276 MS9275 MS9273 MFG DATE 21 01 2023 DATA | $50.0K | 1 |
Sandoz Private Limited exports 35 distinct Furosemide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERI with 12 shipments worth $499.5K.
Regulatory Requirements: Exporting Furosemide to Key Markets
What Sandoz Private Limited must comply with to export Furosemide to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sandoz Private Limited Compare to Nearest Furosemide Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AVET LIFESCIENCES PRIVATE LIMITED | $2.7M | 58 | 1 | $46.2K |
| 6 | MYLAN LABORATORIES LIMITED | $2.3M | 58 | 1 | $40.2K |
| 7 | SANDOZ PRIVATE LIMITED ★ | $2.3M | 88 | 2 | $26.4K |
| 9 | GLAND PHARMA LIMITED | $1.9M | 46 | 5 | $42.3K |
| 8 | EMCURE PHARMACEUTICALS LIMITED | $1.8M | 36 | 1 | $50.0K |
Sandoz Private Limited ranks #7 among 333 Indian Furosemide exporters. Average shipment value of $26.4K compared to the market average of $131.0K. The closest competitors by value are AVET LIFESCIENCES PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Furosemide Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 828 | 17.8% |
| HYDERABAD ICD (INSNF6) | 527 | 11.3% |
| SAHAR AIR | 417 | 9.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 401 | 8.6% |
| NHAVA SHEVA SEA (INNSA1) | 312 | 6.7% |
| ICD SANATHNAGAR, HYD | 162 | 3.5% |
| JNPT/ NHAVA SHEVA SEA | 137 | 2.9% |
| HYDERABAD AIR | 129 | 2.8% |
Geopolitical & Trade Policy Impact on Sandoz Private Limited's Furosemide Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.
Sandoz Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.
The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.
About Sandoz Private Limited
Sandoz Private Limited exports 25 products worth $159.4M. Beyond Furosemide, top products include Tacrolimus, Apixaban, Citalopram, Escitalopram, Gabapentin. View the complete Sandoz Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 88 individual customs records matching Sandoz Private Limited exporting Furosemide, covering 35 formulations to 2 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 778+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Furosemide Export Data from Sandoz Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sandoz Private Limited's Furosemide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sandoz Private Limited
Full Company Profile →
25 products · $159.4M total trade · 15 categories
Furosemide Stats
Company Overview
Top Products by Sandoz Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sandoz Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Furosemide. For current shipment-level data, contact TransData Nexus.